Sara Valpione
- Oncology top 2%
- Immunology top 5%
- Biotechnology top 0.5%
- Molecular Biology
- Biomedical Engineering top 10%
- Co-authors
- L CampanaSimone MocellinJacopo PigozzoCarlo Riccardo RossiVanna Chiarion‐SileniRichard MaraisPaul LoriganGregor Serša
- Topics
- Microbial Inactivation Methods (16 papers)Cancer Immunotherapy and Biomarkers (13 papers)CAR-T cell therapy research (10 papers)
- Cited by
- BiotechnologyOncologyImmunology
- Partner nations
- ItalyUnited KingdomGermany
In The Last Decade
Sara Valpione
47 papers receiving 2.4k citations
Peers
Comparison fields: 5 of 115
- Oncology 1.2k
- Immunology 781
- Biotechnology 628
- Molecular Biology 478
- Biomedical Engineering 385
Countries citing papers authored by Sara Valpione
This map shows the geographic impact of Sara Valpione's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sara Valpione with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sara Valpione more than expected).
Fields of papers citing papers by Sara Valpione
This network shows the impact of papers produced by Sara Valpione. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sara Valpione. The network helps show where Sara Valpione may publish in the future.
Co-authorship network of co-authors of Sara Valpione
This figure shows the co-authorship network connecting the top 25 collaborators of Sara Valpione. A scholar is included among the top collaborators of Sara Valpione based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sara Valpione. Sara Valpione is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 6 | |
| 2 | 8 | |
| 3 | 26 | |
| 4 | 144 | |
| 5 | 22 | |
| 6 | 28 | |
| 7 | 82 | |
| 8 | 139 | |
| 9 | 43 | |
| 10 | 116 | |
| 11 | 3 | |
| 12 | 2 | |
| 13 | 46 | |
| 14 | 50 | |
| 15 | 46 | |
| 16 | 23 | |
| 17 | 18 | |
| 18 | 25 | |
| 19 | 13 | |
| 20 | 11 |
About Sara Valpione
Sara Valpione is a scholar working on Biotechnology, Oncology and Immunology, having authored 47 papers that have together received 2.4k indexed citations. Recurring topics across this work include Microbial Inactivation Methods (16 papers), Cancer Immunotherapy and Biomarkers (13 papers) and CAR-T cell therapy research (10 papers). The work is most often cited by research in Biotechnology (628 citations), Oncology (1.2k citations) and Immunology (781 citations). Sara Valpione has collaborated with scholars based in Italy, United Kingdom and Germany. Frequent co-authors include L Campana, Simone Mocellin, Jacopo Pigozzo, Carlo Riccardo Rossi, Vanna Chiarion‐Sileni, Richard Marais, Paul Lorigan, Gregor Serša, Piyushkumar A. Mundra and Damijan Miklavčič. Their work appears in journals such as Nature Communications, Journal of Clinical Oncology and PLoS ONE.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.